StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
IXICO plc
LSE:IXI.L
Sector
Location
Market Cap
USD 12.27 M
Share Price
USD 0.13
Avg Daily Volume
67,240
Change (1 day)
-0.65%
Change (1 year)
47.71%
Change (YTD)
-9.93%
IXICO plc Operating Cash Flow for the year ending September 30, 2024: USD -2.32 M
IXICO plc Operating Cash Flow is USD -2.32 M for the year ending September 30, 2024, a -728.58% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
IXICO plc Operating Cash Flow for the year ending September 30, 2023 was USD 368.50 K, a -76.90% change year over year.
-
IXICO plc Operating Cash Flow for the year ending September 30, 2022 was USD 1.60 M, a 92.87% change year over year.
-
IXICO plc Operating Cash Flow for the year ending September 30, 2021 was USD 827.09 K, a -66.93% change year over year.
-
IXICO plc Operating Cash Flow for the year ending September 30, 2020 was USD 2.50 M, a -1,665.82% change year over year.
Competitors
Natera, Inc.
USD 158.48
NTRA
-0.21
-0.13%
Veracyte, Inc.
USD 26.58
VCYT
+0.24
0.91%
Boston Scientific Corporation
USD 102.41
BSX
-1.42
-1.37%
RELX Plc
USD 53.63
REL.L
+0.13
0.24%
Siemens Healthineers AG
USD 55.00
SHL.DE
+0.44
0.81%
Cencora, Inc.
USD 298.03
COR
-4.47
-1.48%
Edwards Lifesciences Corporation
USD 76.39
EW
-0.30
-0.39%
GE HealthCare Technologies Inc.
USD 75.20
GEHC
+0.59
0.79%
DexCom, Inc.
USD 83.76
DXCM
+0.82
0.99%
IQVIA Holdings Inc.
USD 164.47
IQV
+2.02
1.24%
Laboratory Corporation of America Holdings
USD 257.45
LH
-0.42
-0.16%
Illumina, Inc.
USD 99.27
ILMN
+2.12
2.18%
Baxter International Inc.
USD 30.66
BAX
+0.97
3.27%
Somnigroup International Inc
USD 71.69
SGI
-0.24
-0.33%
Hologic, Inc.
USD 64.90
HOLX
+0.53
0.82%
Torrent Pharmaceuticals Limited
USD 38.73
TORNTPHARM.NS
-0.02
-0.05%
Fisher & Paykel Healthcare Corporation Limited
USD 22.01
FPH.NZ
-0.10
-0.46%
ICON Public Limited Company
USD 151.58
ICLR
+3.99
2.70%
Zydus Lifesciences Limited
USD 11.41
ZYDUSLIFE.NS
-0.06
-0.54%
Regencell Bioscience Holdings Limited
USD 19.31
RGC
+0.88
4.78%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Natera, Inc.
USD 158.48
NTRA
-0.21
-0.13%
Veracyte, Inc.
USD 26.58
VCYT
+0.24
0.91%
Boston Scientific Corporation
USD 102.41
BSX
-1.42
-1.37%
RELX Plc
USD 53.63
REL.L
+0.13
0.24%
Siemens Healthineers AG
USD 55.00
SHL.DE
+0.44
0.81%
Cencora, Inc.
USD 298.03
COR
-4.47
-1.48%
Edwards Lifesciences Corporation
USD 76.39
EW
-0.30
-0.39%
GE HealthCare Technologies Inc.
USD 75.20
GEHC
+0.59
0.79%
DexCom, Inc.
USD 83.76
DXCM
+0.82
0.99%
IQVIA Holdings Inc.
USD 164.47
IQV
+2.02
1.24%
Laboratory Corporation of America Holdings
USD 257.45
LH
-0.42
-0.16%
Illumina, Inc.
USD 99.27
ILMN
+2.12
2.18%
Baxter International Inc.
USD 30.66
BAX
+0.97
3.27%
Somnigroup International Inc
USD 71.69
SGI
-0.24
-0.33%
Hologic, Inc.
USD 64.90
HOLX
+0.53
0.82%
Torrent Pharmaceuticals Limited
USD 38.73
TORNTPHARM.NS
-0.02
-0.05%
Fisher & Paykel Healthcare Corporation Limited
USD 22.01
FPH.NZ
-0.10
-0.46%
ICON Public Limited Company
USD 151.58
ICLR
+3.99
2.70%
Zydus Lifesciences Limited
USD 11.41
ZYDUSLIFE.NS
-0.06
-0.54%
Regencell Bioscience Holdings Limited
USD 19.31
RGC
+0.88
4.78%